Trametinib

A summary of the most common chemical descriptors (InChI Key and SMILES codes) for Trametinib are summarized together with 3D and 2D structures and relevant physico-chemical properties.

What is the Trametinib?

The molecule Trametinib presents a molecular formula of C26H23FIN5O4 and its IUPAC name is N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide.

Trametinib (trade name Mekinist) is a kinase inhibitor indicated for the treatment of melanoma. It is a small molecule that specifically inhibits the MEK1 and MEK2 enzymes..

Trametinib was discovered by a team of researchers at the Dana-Farber Cancer Institute and the Harvard School of Medicine. The drug was originally developed by GlaxoSmithKline, but is now marketed by Novartis..

Trametinib has shown efficacy in clinical trials as a monotherapy and in combination with other drugs. In a phase III trial, trametinib in combination with dabrafenib (Tafinlar) was shown to improve overall survival compared to dabrafenib alone..

The most common side effects of trametinib include rash, diarrhea, fatigue, and nausea. Trametinib can also cause serious side effects, such as heart failure and pneumonitis..

Trametinib is a promising new treatment for melanoma, but more research is needed to determine its long-term efficacy and safety..

3D structure

Cartesian coordinates

Geometry of Trametinib in x, y and z coordinates (Å units) to copy/paste elsewhere. Generated with Open Babel software.

2D drawing

 

Trametinib LIRYPHYGHXZJBZ-UHFFFAOYSA-N chemical compound 2D structure molecule svg
Trametinib

 

Molecule descriptors

 
IUPAC nameN-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide
InChI codeInChI=1S/C26H23FIN5O4/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34)
InChI KeyLIRYPHYGHXZJBZ-UHFFFAOYSA-N
SMILESCC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1

Other names (synonyms)

IUPAC nomenclature provides a standardized method for naming chemical compounds. Although this system is widely used in chemistry, many chemical compounds have also other names commonly used in different contexts. These synonyms can come from a variety of sources and are used for a variety of purposes.

One common source of synonyms for chemical compounds is the common or trivial names, assigned on the basis of appearance, properties, or origin of the molecule.

Another source of synonyms are historical or obsolete names employed in the past, however replaced nowadays by more modern or standardized names.

In addition to common and historical names, chemical compounds may also have synonyms that are specific to a particular field or industry.

  • 33E86K87QN
  • 871700-17-3
  • A1-01871
  • A25168
  • AC-25891
  • AM90271
  • AS-19382
  • Acetamide, N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-3,4,6,7-tetrahydro-6,8- dimethyl-2,4,7-trioxopyrido(4,3-d)pyrimidin-1(2H)-yl)phenyl)-
  • Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-
  • BCP02307
  • BCPP000218
  • BDBM50531540
  • CCG-264976
  • CS-0060
  • D10175
  • DB08911
  • EX-5957
  • EX-A022
  • FT-0688438
  • GSK 1120212
  • GSK-1120212
  • GSK1120212
  • GSK1120212 (Trametinib)
  • GSK1120212 - JTP-74057
  • GSK1120212,JTP-74057, GSK212
  • GSK212
  • GTPL6495
  • HMS3295I05
  • HMS3656J11
  • HY-10999
  • J-523325
  • JTP 74057
  • JTP-74057
  • JTP74057
  • MFCD17215075
  • Mekinist
  • N-(3-(3-CYCLOPROPYL-5-((2-FLUORO-4-IODOPHENYL)AMINO)-6,8-DIMETHYL-2,4,7-TRIOXO-3,4,6,7-TETRAHYDROPYRIDO(4,3-D)PYRIMIDIN-1(2H)-YL)PHENYL)ACETAMIDE
  • N-(3-(3-Cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7- tetrahydropyrido(4,3-d)pyrimidin-1(2H)-yl)phenyl)acetamide
  • N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide
  • N-(3-(3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide
  • N-(3-{3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7- tetrahydropyrido(4,3-d)pyrimidin-1(2H)-yl}phenyl)acetamide
  • N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide
  • N-[3-[3-Cyclopropyl-5-[(2-Fluoro-4-Iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2h)-yl]phe nyl]acetamide
  • N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]acetamide
  • N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodo-anilino)-6,8-dimethyl-2,4,7-trioxo-pyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide
  • N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide
  • N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxopyrido[3,4-e]pyrimidin-1-yl]phenyl]acetamide
  • N-{3-[3-Cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl}ethanimidic acid
  • N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide
  • NCGC00263180-01
  • NCGC00263180-07
  • NCGC00263180-14
  • NSC-758246
  • NSC-800956
  • NSC758246
  • NSC800956
  • Q7833138
  • QOM
  • SB16553
  • SR-01000941589
  • SR-01000941589-1
  • SW218089-2
  • TMT-212
  • TMT212
  • Trametinib
  • Trametinib (GSK1120212)
  • Trametinib (GSK1120212JTP 74057)
  • Trametinib (USAN)
  • s2673
  • trametinibum

Reference codes for other databases

There exist several different chemical codes commonly used in orded to identify molecules:
  • ZINC43100709
  • UNII-33E86K87QN
  • AKOS015850628
  • BRD-K12343256-001-01-4
  • DTXSID901007381
  • CHEMBL2103875
  • CHEBI:75998
  • SCHEMBL170938

Physico-Chemical properties

IUPAC nameN-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide
Molecular formulaC26H23FIN5O4
Molecular weight615.395
Melting point (ºC)
Boiling point (ºC)
Density (g/cm3)
Molar refractivity149.59
LogP4.1
Topological polar surface area107.1

LogP and topological polar surface area (TPSA) values were estimated using Open Babel software.

The n-octanol/water partition coeficient (Kow) data is applied in toxicology and drug research. Kow values are used, to guess the environmental fate of persistent organic pollutants. High partition coefficients values, tend to accumulate in the fatty tissue of organisms. Molecules with a log(Kow) (or LogP) greater than 5 are considered to bioaccumulate.

TPSA values are the sum of the surface area over all polar atoms or molecules, mainly oxygen and nitrogen, also including hydrogen atoms.

In medicinal chemistry, TPSA is used to assess the ability of a drug to permeabilise cells.

For molecules to penetrate the blood-brain barrier (and act on receptors in the central nervous system), TPSA values below 90 Å2 are required. Thus, molecules with a polar surface area greater than 140 Å2 tend to be poorly permeable to cell membranes.